The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea

PURPOSE: The model for end-stage liver disease (MELD) 3.0 has recently been suggested for determining liver allocation. We aimed to apply MELD 3.0 to a Korean population and to discover differences between patients with and without hepatocellular carcinoma (HCC). MATERIALS AND METHODS: This study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kunhee, Kim, Deok-Gie, Lee, Jae Geun, Joo, Dong Jin, Lee, Hye Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613763/
https://www.ncbi.nlm.nih.gov/pubmed/37880845
http://dx.doi.org/10.3349/ymj.2023.0163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613763/
https://www.ncbi.nlm.nih.gov/pubmed/37880845
http://dx.doi.org/10.3349/ymj.2023.0163

Ejemplares similares